AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Plunge Analysis
/
Hans Biomed Corp.
/
2026-05-07
▼ PLUNGE
Hans Biomed Corp.
-21.2%
042520
KRX
Healthcare
2026-05-07
23,250
Close
29,500
Prev Close
-21.19%
Change
6.1x
Vol Ratio
Why It Plunged
No related news available.
Related News
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
After scrapping AXN-2510, Instil Bio hunts for new drug deals
Stocktitan
2026-03-27
Harvard Bioscience shares are trading higher after the company reported preliminary Q4 results, issued FY26 outlook and outlined its long-term strategic focus areas. - Harvard Bioscience (NASDAQ:HBIO)
Benzinga
2026-02-10
Fractyl Health sets March 24 call on 2025 results, business updates
Stocktitan
2026-03-17
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
Technical Analysis
Signals
BB Lower Break
Oversold
MACD Bearish
Below SMA20
Key Indicators
29.29
RSI (14)
31710.00
SMA 20
26213.24
Bollinger Lower
37206.75
Bollinger Upper
31710.00
Bollinger Mid
-2835.53
MACD
-2496.69
MACD Signal
-338.84
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Hans Biomed Corp. Surged +-21.2% on 2026-05-07 — Analysis | Alpha Lenz